ArticleThe Journal of antimicrobial chemotherapy2017

Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings.

Giulia Cucchetto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.